Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explores the emerging role of tumour necrosis factor receptor-associated factor 6 including the challenges and opportunities in this vein.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
University of Manchester and University of North Texas scientists identify that an embryonic living heart can be programmed to survive a low oxygen environment in later life.
Patients who have been diagnosed with diabetes are at a lower risk of early death if they have a doctor who they describe as showing empathy towards them, a new study from the University of Cambridge has found.
Tea is the nation’s favourite drink and for good reason: it not only tastes great, but it’s good for our wellbeing as it is full of healthy ingredients.
A new study supported by the World Health Organisation found that higher dietary fibre intake is associated with a reduced risk of several chronic diseases.
Employees are wrongly assuming that keeping active during leisure time will protect them from the danger of sitting for long periods when working in an office, a new study has found
Simon Gillespie, Chief Executive of the British Heart Foundation ponders if escalating diabetes rates could reverse success in reducing heart disease deaths
Scientific progress to grow new tissues outside of the human body led to first market approvals of living tissue-engineered implants
The creation of living tissues...
Researchers at Cleveland Clinic, University of Oxford, and University of Erlangen have identified a novel imaging biomarker – and found it can be used to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries
Public Health England (PHE) is calling for adults to take a free, online Heart Age Test, which will provide an immediate estimation of their 'heart age' to help prevent heart attacks and strokes
Researchers at Cleveland Clinic in the United States have designed a potential new class of drugs that may reduce cardiovascular diseases by targeting a specific microbial pathway in the gut.
CARMAT today confirms the announcement by the National Research Center for Cardiac Surgery on the successful transplant of a donor heart in the first international patient implanted with the CARMAT heart in October 2017
